Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2,278 out of 166,615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 83,213 | 83,245 |
| Total Cites | 11,746 | 13,872 |
| H-index | 52 | 57 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 45 | 45 |
| Number of Single+First Authored Papers | 55 | 55 |
| Total Cites to Single+First Authored Papers | 3,802 | 4,430 |
| Number of Single+First+Last Authored Papers | 68 | 68 |
| Total Cites to Single+First+Last Authored Papers | 3,982 | 4,652 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8,347 | 9,210 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.51 |
| Self-Citation Percentage |
15.33%
|
|
Rossi, Davide
Università degli Studi del Piemonte Orientale “Amedeo Avogadro”,
Italy
2024 Rank: 88,704
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2,450 out of 157,372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 88,704 | 89,945 |
| Total Cites | 10,955 | 12,978 |
| H-index | 50 | 56 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 31 | 31 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 3,580 | 4,196 |
| Number of Single+First+Last Authored Papers | 66 | 66 |
| Total Cites to Single+First+Last Authored Papers | 3,738 | 4,395 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7,829 | 8,634 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.50 |
| Self-Citation Percentage |
15.59%
|
|
Rossi, Davide
Università degli Studi del Piemonte Orientale Amedeo Avogadro,
Italy
2023 Rank: 82,360
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2,325 out of 147,556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 82,360 | 84,351 |
| Total Cites | 10,776 | 12,850 |
| H-index | 51 | 56 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 31 | 31 |
| Number of Single+First Authored Papers | 55 | 55 |
| Total Cites to Single+First Authored Papers | 3,399 | 3,998 |
| Number of Single+First+Last Authored Papers | 67 | 67 |
| Total Cites to Single+First+Last Authored Papers | 3,546 | 4,186 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7,676 | 8,495 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.51 |
| Self-Citation Percentage |
16.14%
|
|
Rossi, Davide
Università degli Studi del Piemonte Orientale Amedeo Avogadro,
Italy
2022 Rank: 76,677
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2,223 out of 138,599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 76,677 | 78,685 |
| Total Cites | 10,191 | 12,193 |
| H-index | 51 | 56 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 30 | 30 |
| Number of Single+First Authored Papers | 55 | 55 |
| Total Cites to Single+First Authored Papers | 3,206 | 3,769 |
| Number of Single+First+Last Authored Papers | 67 | 67 |
| Total Cites to Single+First+Last Authored Papers | 3,345 | 3,947 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7,220 | 8,010 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.52 |
| Self-Citation Percentage |
16.42%
|
|
Rossi, Davide
Università degli Studi del Piemonte Orientale Amedeo Avogadro,
Italy
2021 Rank: 75,956
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2,209 out of 127,911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 75,956 | 75,720 |
| Total Cites | 9,836 | 11,791 |
| H-index | 50 | 56 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 30 | 30 |
| Number of Single+First Authored Papers | 55 | 55 |
| Total Cites to Single+First Authored Papers | 3,106 | 3,657 |
| Number of Single+First+Last Authored Papers | 67 | 67 |
| Total Cites to Single+First+Last Authored Papers | 3,237 | 3,826 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6,938 | 7,700 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.53 |
| Self-Citation Percentage |
16.58%
|
|
Rossi, Davide
Università degli Studi del Piemonte Orientale Amedeo Avogadro,
Italy
2020 Rank: 74,753
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2,144 out of 108,509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 74,753 | 74,785 |
| Total Cites | 8,831 | 10,671 |
| H-index | 47 | 53 |
| Hm-index | 11 | 12 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 29 | 29 |
| Number of Single+First Authored Papers | 56 | 56 |
| Total Cites to Single+First Authored Papers | 2,770 | 3,287 |
| Number of Single+First+Last Authored Papers | 68 | 68 |
| Total Cites to Single+First+Last Authored Papers | 2,880 | 3,434 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6,261 | 6,976 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.53 |
| Self-Citation Percentage |
17.24%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.